154 related articles for article (PubMed ID: 36505825)
1. Editorial: Megakaryocytes as regulators of tumor microenvironments.
Migliaccio AR; Balduini A; Zhan H
Front Oncol; 2022; 12():1090658. PubMed ID: 36505825
[No Abstract] [Full Text] [Related]
2. Resident Self-Tissue of Proinflammatory Cytokines Rather Than Their Systemic Levels Correlates with Development of Myelofibrosis in
Zingariello M; Verachi P; Gobbo F; Martelli F; Falchi M; Mazzarini M; Valeri M; Sarli G; Marinaccio C; Melo-Cardenas J; Crispino JD; Migliaccio AR
Biomolecules; 2022 Jan; 12(2):. PubMed ID: 35204735
[TBL] [Abstract][Full Text] [Related]
3. Megakaryocytes Are Regulators of the Tumor Microenvironment and Malignant Hematopoietic Progenitor Cells in Myelofibrosis.
Varricchio L; Hoffman R
Front Oncol; 2022; 12():906698. PubMed ID: 35646681
[TBL] [Abstract][Full Text] [Related]
4. PD-L1 expression in megakaryocytes and its clinicopathological features in primary myelofibrosis patients.
Lee SH; Lin CC; Wei CH; Chang KP; Yuan CT; Tsai CH; Liu JH; Hou HA; Tang JL; Chou WC; Tien HF
J Pathol Clin Res; 2022 Jan; 8(1):78-87. PubMed ID: 34480529
[TBL] [Abstract][Full Text] [Related]
5. Aurora Kinase A Inhibition Provides Clinical Benefit, Normalizes Megakaryocytes, and Reduces Bone Marrow Fibrosis in Patients with Myelofibrosis: A Phase I Trial.
Gangat N; Marinaccio C; Swords R; Watts JM; Gurbuxani S; Rademaker A; Fought AJ; Frankfurt O; Altman JK; Wen QJ; Farnoud N; Famulare CA; Patel A; Tapia R; Vallapureddy RR; Barath S; Graf A; Handlogten A; Zblewski D; Patnaik MM; Al-Kali A; Dinh YT; Englund Prahl K; Patel S; Nobrega JC; Tejera D; Thomassen A; Gao J; Ji P; Rampal RK; Giles FJ; Tefferi A; Stein B; Crispino JD
Clin Cancer Res; 2019 Aug; 25(16):4898-4906. PubMed ID: 31061068
[TBL] [Abstract][Full Text] [Related]
6. Tetraspanin CD9 participates in dysmegakaryopoiesis and stromal interactions in primary myelofibrosis.
Desterke C; Martinaud C; Guerton B; Pieri L; Bogani C; Clay D; Torossian F; Lataillade JJ; Hasselbach HC; Gisslinger H; Demory JL; Dupriez B; Boucheix C; Rubinstein E; Amsellem S; Vannucchi AM; Le Bousse-Kerdilès MC
Haematologica; 2015 Jun; 100(6):757-67. PubMed ID: 25840601
[TBL] [Abstract][Full Text] [Related]
7. Megakaryocytic morphology and clinical parameters in essential thrombocythemia, polycythemia vera, and primary myelofibrosis with and without JAK2 V617F.
Vytrva N; Stacher E; Regitnig P; Zinke-Cerwenka W; Hojas S; Hubmann E; Porwit A; Bjorkholm M; Hoefler G; Beham-Schmid C
Arch Pathol Lab Med; 2014 Sep; 138(9):1203-9. PubMed ID: 25171702
[TBL] [Abstract][Full Text] [Related]
8. Megakaryocytes in cubital venous blood in patients with chronic myeloproliferative diseases.
Tinggaard Pedersen N; Laursen B
Scand J Haematol; 1983 Jan; 30(1):50-8. PubMed ID: 6573016
[TBL] [Abstract][Full Text] [Related]
9. Shared and Distinctive Ultrastructural Abnormalities Expressed by Megakaryocytes in Bone Marrow and Spleen From Patients With Myelofibrosis.
Zingariello M; Rosti V; Vannucchi AM; Guglielmelli P; Mazzarini M; Barosi G; Genova ML; Migliaccio AR
Front Oncol; 2020; 10():584541. PubMed ID: 33312951
[TBL] [Abstract][Full Text] [Related]
10. The Role of Megakaryocytes in Myelofibrosis.
Melo-Cardenas J; Migliaccio AR; Crispino JD
Hematol Oncol Clin North Am; 2021 Apr; 35(2):191-203. PubMed ID: 33641863
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of CXCR1/2 reduces the emperipolesis between neutrophils and megakaryocytes in the Gata1
Arciprete F; Verachi P; Martelli F; Valeri M; Balliu M; Guglielmelli P; Vannucchi AM; Migliaccio AR; Zingariello M
Exp Hematol; 2023 May; 121():30-37. PubMed ID: 36863479
[TBL] [Abstract][Full Text] [Related]
12. Involvement of transforming growth factor-beta and thrombopoietin in the pathogenesis of myelodysplastic syndrome with myelofibrosis.
Akiyama T; Matsunaga T; Terui T; Miyanishi K; Tanaka I; Sato T; Kuroda H; Takimoto R; Takayama T; Kato J; Yamauchi N; Kogawa K; Sakamaki S; Hirayama Y; Kohda K; Niitsu Y
Leukemia; 2005 Sep; 19(9):1558-66. PubMed ID: 16034467
[TBL] [Abstract][Full Text] [Related]
13. Myelofibrosis and acute megakaryoblastic leukemia in a child: topographic relationship between fibroblasts and megakaryocytes with an alpha-granule defect.
Breton-Gorius J; Bizet M; Reyes F; Dupuy E; Mear C; Vannier JP; Tron P
Leuk Res; 1982; 6(1):97-110. PubMed ID: 6461801
[TBL] [Abstract][Full Text] [Related]
14. TGF-beta and megakaryocytes in the pathogenesis of myelofibrosis in myeloproliferative disorders.
Martyré MC
Leuk Lymphoma; 1995 Dec; 20(1-2):39-44. PubMed ID: 8750621
[TBL] [Abstract][Full Text] [Related]
15. Novel targets to cure primary myelofibrosis from studies on Gata1
Zingariello M; Martelli F; Verachi P; Bardelli C; Gobbo F; Mazzarini M; Migliaccio AR
IUBMB Life; 2020 Jan; 72(1):131-141. PubMed ID: 31749302
[TBL] [Abstract][Full Text] [Related]
16. Specific Features of Interactions between Megakaryocytic and Granulocytic Hematopoiesis Lineages and Myelofibrosis during the Acute Phase of Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia, and Multiple Myeloma.
Dolgikh TY; Senchukova SR; Vinogradova EV; Krinitsyna YM
Bull Exp Biol Med; 2020 Apr; 168(6):734-738. PubMed ID: 32333309
[TBL] [Abstract][Full Text] [Related]
17. Generation of induced pluripotent stem cells derived from primary and secondary myelofibrosis patient samples.
Hosoi M; Kumano K; Taoka K; Arai S; Kataoka K; Ueda K; Kamikubo Y; Takayama N; Otsu M; Eto K; Nakauchi H; Kurokawa M
Exp Hematol; 2014 Sep; 42(9):816-25. PubMed ID: 24859480
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of myelofibrosis with myeloid metaplasia: Insight from mouse models.
Chagraoui H; Wendling F; Vainchenker W
Best Pract Res Clin Haematol; 2006; 19(3):399-412. PubMed ID: 16781480
[TBL] [Abstract][Full Text] [Related]
19. Focus on Osteosclerotic Progression in Primary Myelofibrosis.
Spampinato M; Giallongo C; Romano A; Longhitano L; La Spina E; Avola R; Scandura G; Dulcamare I; Bramanti V; Di Rosa M; Vicario N; Parenti R; Li Volti G; Tibullo D; Palumbo GA
Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33477816
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of FKBP51 in idiopathic myelofibrosis regulates the growth factor independence of megakaryocyte progenitors.
Giraudier S; Chagraoui H; Komura E; Barnache S; Blanchet B; LeCouedic JP; Smith DF; Larbret F; Taksin AL; Moreau-Gachelin F; Casadevall N; Tulliez M; Hulin A; Debili N; Vainchenker W
Blood; 2002 Oct; 100(8):2932-40. PubMed ID: 12351405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
